Advertisement
Screener

Protalix BioTherapeutics, Inc. (PLX) Interest Expense

Protalix BioTherapeutics, Inc. Interest Expense

Protalix BioTherapeutics, Inc. (PLX) reported Interest Expense of $3.55 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-08.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2016-03-08

  • Protalix BioTherapeutics, Inc. interest expense for the quarter ending 2013-12-31 was $896.00K.
  • Protalix BioTherapeutics, Inc. interest expense for the quarter ending 2013-09-30 was $119.00K.
  • Protalix BioTherapeutics, Inc. interest expense for fiscal 2015 was $3.55M, a 0.00% change from fiscal 2014.
  • Protalix BioTherapeutics, Inc. interest expense for fiscal 2014 was $3.55M, a 249.66% increase from fiscal 2013.
  • Protalix BioTherapeutics, Inc. interest expense for fiscal 2013 was $1.01M.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2015-12-31$3.55M
10-K · filed 2016-03-08
2014-12-31$3.55M
10-K · filed 2016-03-08
2013-12-31$896.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08
$1.01M
derived: sum of 2 quarters · filed 2016-03-08
$1.01M
10-K · filed 2016-03-08
2013-09-30$119.00K
10-Q · filed 2013-11-07
$119.00K
10-Q · filed 2013-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95